Affordable Access

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results.

Authors
Type
Published Article
Journal
Blood
Publication Date
Volume
108
Issue
1
Pages
28–37
Identifiers
PMID: 16522812
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments